Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Epicore Bionetworks Inc. V.EBN

"Epicore Bionetworks Inc develops, manufactures and markets biotechnology products based on natural microbes and enzymes for the aquaculture, agriculture and municipal industries."


TSXV:EBN - Post by User

Post by billy4325on Feb 15, 2017 9:54am
105 Views
Post# 25848213

Q2 Results

Q2 Resultshttps://www.newswire.ca/news-releases/epicore-bionetworks-inc-reports-quarter-two-results-for-fiscal-year-2017-613755553.html

Good news!

EASTAMPTON, NJ, Feb. 14, 2017 /CNW/ - Epicore BioNetworks Inc. (TSXV EBN) reported second quarter revenue of $3.0 million and net income of $0.7 million or $0.03 per share for the period ended December 31, 2016. 

Second quarter revenue was 36% higher than last year's Q2.  Revenue for the first six months at $5.4 million was 28% higher than last year's first half. Net income was $0.7 million in Q2, an increase of $0.6 million or 603% over prior year Q2 bringing first half net income to $0.9 million compared to $0.3 million in fiscal 2016. Sales grew in all business sectors except non-aqua.  The largest revenue increase was in Latin America but Asia had the largest percentage increase. 

The shrimp industry began to recover in Q3 of fiscal 2016 as shrimp prices started to rise. Prices continue to slowly increase.  Also, the industry has begun to adapt to disease presence by improving culturing practices such as the use of raceway systems.  Disease prevalence in Asia and Mexico inhibits sales recovery to 2015 levels so shrimp production will be slow to recover.  But, with higher shrimp prices farmers are more willing to try a crop, which is good for Epicore's hatchery product sales.

Results versus prior fiscal year quarter two are as follows:

  • Q2 revenue of $3.0 million was 36% higher than Q2 last year
  • Q2 gross profit of $1.8 million was 54% higher than Q2 last year
  • Q2 operating expenses of $1.0 million were 1% higher than Q2 last year
  • Q2 earnings before taxes of $0.8 million were 382% higher than Q2 last year
  • Q2 net income of $0.7 million was 603% higher than Q2 last year
  • Q2 EBITDA1 of $0.9 million was 280% higher than last year Q2
  • Q2 basic earnings per share of $0.03 were 575% higher than Q2 last year
  • Q2 shareholders' equity of $10.4 million was 22% higher than Q2 last year
  • Q2 cash balance of $3.5 million was 107% higher than Q2 last year
  • YTD cash flow from operating activities was $0.3 million

 

Gross profit increased 54% in Q2 due to the increase in revenues and to a higher average selling price due to product sales mix.  Operating expense was controlled to a small increase of 1% over prior year Q2 and only a 3% increase for the first six months.  Efficiencies were created from recent capital expenditures.

Higher gross profit and relatively controlled expenses increased net income by 603% to $0.7 million versus prior year Q2.  Taxes at $0.1 million were only 57% above prior year Q2 because of process equipment expenditures tax credits. The following table summarizes the Q2 results (rounded to thousands of US dollars):

 

For the Quarter ended December 31

 

2016

2015

Increase (Decrease)

Revenue

$2,952

$2,178

$774

36%

Gross profit

$1,828

$1,184

$644

54%

Operating expenses

$1,028

$1,022

$6

1%

Net income

$696

$99

$597

603%

Earnings per share

$0.027

$0.004

$0.023

575%

Shareholders' equity

$10,395

$8,528

$1,004

22%

Cash balance

$3,508

$1,693

$1,815

107%

                                               

Epicore continues to generate positive net income from operating activities. Cash at the end of the quarter was $3.5 million versus $3.4 million, the same as the end of fiscal 2016. With these funds, expected sales revenue growth and continued relatively low operating costs, management expects there will be sufficient cash to meet the fiscal year's financial requirements, to fund expansion of aquaculture and environmental remediation marketing efforts and to pursue new strategies for enhancing shareholder value. 

Over the last two years, Epicore has invested materially in a second building and automated packaging equipment.  This added space has been critical to our ability to increase production levels.  All automated packaging equipment is in place and operational.  The board has approved an ongoing capital program to enhance efficiencies and ensure redundancies in critical applications of our operations.

<< Previous
Bullboard Posts
Next >>